Neurology

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.

This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.

This week’s Research Roundup highlights rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease.

This week’s Research Roundup highlights urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia.

This week’s Research Roundup highlights expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG positive patients.

This week’s Research Roundup highlights the single-nephron glomerular filtration rate in healthy adults.

This week’s Research Roundup highlights the management of diffuse low-grade gliomas in adults.

The algorithm can be viewed here.

Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells.